XML 54 R44.htm IDEA: XBRL DOCUMENT
v2.4.1.9

Business segment information (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2013
Segment Reporting [Abstract] |
Schedule of External Net Sales by SBU Reporting Segment | External Net Sales by SBU: The table below presents external net sales for continuing operations by SBU reporting segment. Net sales include product sales and marketing service fees.
|  | External Net Sales by SBU Year ended December 31, |
(U.S. Dollars in thousands) |  | 2013 |  |  | 2012 |  |  | 2011 |
|  | Net Sales |  |  | Percent of Total Net Sales |  |  | Net Sales |  |  | Percent of Total Net Sales |  |  | Net Sales |  |  | Percent of Total Net Sales |
|  | (Restated) |  |  | (Restated) |  |  | (Restated) |
BioStim |  | $ | 145,085 |  |  |  | 36 | % |  | $ | 174,562 |  |  |  | 40 | % |  | $ | 181,736 |  |  |  | 42 | %
Biologics |  |  | 53,746 |  |  |  | 14 | % |  |  | 53,731 |  |  |  | 12 | % |  |  | 42,910 |  |  |  | 10 | %
Extremity Fixation |  |  | 103,359 |  |  |  | 26 | % |  |  | 112,011 |  |  |  | 25 | % |  |  | 119,504 |  |  |  | 27 | %
Spine Fixation |  |  | 95,421 |  |  |  | 24 | % |  |  | 99,885 |  |  |  | 23 | % |  |  | 91,368 |  |  |  | 21 | %
Total Net Sales |  | $ | 397,611 |  |  |  | 100 | % |  | $ | 440,189 |  |  |  | 100 | % |  | $ | 435,519 |  |  |  | 100 | %
Summary of Net Margin, Defined as Gross Profit Less Sales And Marketing Expenses from Continuing Operations by SBU Reporting Segment | The table below presents net margin, defined as gross profit less sales and marketing expenses from continuing operations by SBU reporting segment:
Net Margin by SBU (U.S. Dollars in thousands) |  | Year Ended December 31, |
| 2013 |  |  | 2012 |  |  | 2011 |
|  | (Restated) |  |  | (Restated) |  |  | (Restated) |
Net Margin |  |  |  |  |  |  |  |  |  |  |  |
BioStim |  | $ | 63,847 |  |  | $ | 88,788 |  |  | $ | 92,860 |
Biologics |  |  | 24,794 |  |  |  | 23,589 |  |  |  | 18,978 |
Extremity Fixation |  |  | 23,704 |  |  |  | 34,554 |  |  |  | 30,773 |
Spine Fixation |  |  | 4,329 |  |  |  | 15,256 |  |  |  | 13,037 |
Corporate |  |  | (1,443 | ) |  |  | (1,495 | ) |  |  | (1,700 | )
Total net margin |  | $ | 115,231 |  |  | $ | 160,692 |  |  | $ | 153,948 |
General & administrative |  |  | 64,830 |  |  |  | 53,650 |  |  |  | 64,785 |
Research and development |  |  | 26,768 |  |  |  | 28,577 |  |  |  | 22,861 |
Amortization of intangible assets |  |  | 2,687 |  |  |  | 2,298 |  |  |  | 2,550 |
Costs related to the accounting review and restatement |  |  | 12,945 |  |  |  | — |  |  |  | — |
Impairment of goodwill |  |  | 19,193 |  |  |  | — |  |  |  | — |
Charges related to U.S. Government resolutions |  |  | — |  |  |  | 1,295 |  |  |  | 57,141 |
Operating (loss) income |  | $ | (11,192 | ) |  | $ | 74,872 |  |  | $ | 6,611 |
Schedule of Depreciation and Amortization by SBU Reporting Segment | The table below presents external net sales for continuing operations by SBU reporting segment. Net sales include product sales and marketing service fees.
|  | External Net Sales by SBU Year ended December 31, |
(U.S. Dollars in thousands) |  | 2013 |  |  | 2012 |  |  | 2011 |
|  | Net Sales |  |  | Percent of Total Net Sales |  |  | Net Sales |  |  | Percent of Total Net Sales |  |  | Net Sales |  |  | Percent of Total Net Sales |
|  | (Restated) |  |  | (Restated) |  |  | (Restated) |
BioStim |  | $ | 145,085 |  |  |  | 36 | % |  | $ | 174,562 |  |  |  | 40 | % |  | $ | 181,736 |  |  |  | 42 | %
Biologics |  |  | 53,746 |  |  |  | 14 | % |  |  | 53,731 |  |  |  | 12 | % |  |  | 42,911 |  |  |  | 10 | %
Extremity Fixation |  |  | 103,359 |  |  |  | 26 | % |  |  | 112,011 |  |  |  | 25 | % |  |  | 119,504 |  |  |  | 27 | %
Spine Fixation |  |  | 95,421 |  |  |  | 24 | % |  |  | 99,885 |  |  |  | 23 | % |  |  | 91,368 |  |  |  | 21 | %
Total Net Sales |  | $ | 397,611 |  |  |  | 100 | % |  | $ | 440,189 |  |  |  | 100 | % |  | $ | 435,519 |  |  |  | 100 | %
Summary of Net Sales by Geographic Destination | The following geographic data includes net sales by geographic destination:
(U.S. Dollars in thousands) |  | 2013 |  |  | 2012 |  |  | 2011 |
|  | (Restated) |  |  | (Restated) |  |  | (Restated) |
U.S. |  | $ | 293,032 |  |  | $ | 327,228 |  |  | $ | 322,186 |
Italy |  |  | 16,755 |  |  |  | 18,742 |  |  |  | 17,447 |
U.K. |  |  | 10,002 |  |  |  | 8,431 |  |  |  | 8,206 |
Brazil |  |  | 26,786 |  |  |  | 31,166 |  |  |  | 34,424 |
Others |  |  | 51,036 |  |  |  | 54,622 |  |  |  | 53,256 |
Total net sales |  | $ | 397,611 |  |  | $ | 440,189 |  |  | $ | 435,519 |
Analysis of Property, Plant and Equipment of Reporting Segments by Geographic Area | Analysis of property, plant and equipment by geographic area:
(U.S. Dollars in thousands) |  | 2013 |  |  | 2012 |
|  | (Restated) |  |  | (Restated) |
U.S. |  | $ | 39,287 |  |  | $ | 38,504 |
Italy |  |  | 8,150 |  |  |  | 7,625 |
U.K. |  |  | 1,871 |  |  |  | 1,402 |
Brazil |  |  | 3,210 |  |  |  | 3,421 |
Others |  |  | 1,854 |  |  |  | 1,841 |
Total |  | $ | 54,372 |  |  | $ | 52,793 |

X
- Definition Contribution Margin By Segment Reporting [Table Text Block] + References No definition available. + Details
Name: | ofix_ContributionMarginBySegmentReportingTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Segment Reporting Information By Segment Depreciation And Amortization [Table Text Block] + References No definition available. + Details
Name: | ofix_ScheduleOfSegmentReportingInformationBySegmentDepreciationAndAmortizationTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenues by reporting segment. + References No definition available. + Details
Name: | ofix_ScheduleOfSegmentReportingRevenuesBySegmentTableTextBlock
Namespace Prefix: | ofix_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of long-lived assets, excluding financial instruments, long-term customer relationships of a financial institution, mortgage rights, deferred policy acquisition costs, and deferred tax assets, by geographic areas located in the entity's country of domicile and foreign countries in which the entity holds assets. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 + Details
Name: | us-gaap_LongLivedAssetsByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of revenue from external customers by geographic areas attributed to the entity's country of domicile and to foreign countries from which the entity derives revenue. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -Subparagraph a -URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9038-108599 + Details
Name: | us-gaap_RevenueFromExternalCustomersByGeographicAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration